Drug & intervention

paricalcitol

RxCUI 73710

Clinical trials8
Recruiting0
Related conditions14
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Paricalcitol

Paricalcitol (chemically it is 19-nor-1,25-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic kidney failure. It is an analog of 1,25-dihydroxyergocalciferol, the active form of vitamin D2 (ergocalciferol). It was patented in 1989 and approved for medical use in 1998.

Read on Wikipedia ↗ Wikidata Q155746 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

8 shown
The Effects of Active VItamin D on Left Atrial Volume IndexNCT01630408 · 2014-03-01
WITHDRAWN
Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 DiabetesNCT01393808 · 2011-09-01
COMPLETED
Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic NephropathyNCT01331317 · 2010-04-01
COMPLETED
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant PatientsNCT01265615 · 2009-10-01
COMPLETED
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone MetastasesNCT00634582 · 2009-01-01
TERMINATED
Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast CancerNCT00637897 · 2008-03-01
COMPLETED
The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4NCT00497146 · 2008-02-01
COMPLETED
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on InflammationNCT00428246 · 2006-11-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.